J of IMAB 2012; 18(4):240-242
APPLICATION OF Nd-YAG LASER TREATMENT FOR ORAL LEUKOPLAKIA
Hristina Lalabonova, Stefka Peycheva, P. Petrov
Department of Maxillofacial Surgery, Faculty of Dental Medicine, Medical University - Plovdiv, Bulgaria.

ABSTRACT:
High energy lasers are used as an alternative to conventional surgery for treatment of oral leukoplakia. The purpose of this study is to monitor the effectiveness of Nd-YAG laser as treatment for oral leukoplakia. Seventeen patients were followed-up with oral leukoplakia for the period 2005-2011. Nd–YAG laser was used with following parameters: λ - 1 064 nm, 10 - 15 W, Т 40 - 70 sec. Early postoperative results were monitored considering criteria pain, redness, swelling each 1, 3, 7 days. The effect from the treatment was determined by recording the changes in size of the lesions each 1, 2, 3 months. The results which reflect effectiveness of treatment within the observed period showed that twelve patients were complete respondents, two responded partially, and three did not respond. The treatment of oral leukoplakia through the application of Nd-YAG laser is characterized with good therapeutic effect and smooth postoperative period, without significant pain and discomfort, making it appropriate clinical solution.

Key words: oral leukoplakia, Nd – YAG laser, treatment.

- Download FULL TEXT /PDF 538 KB/
Please cite this article as: Lalabonova Hr, Peycheva St, Petrov P. APPLICATION OF Nd – YAG LASER TREATMENT FOR ORAL LEUKOPLAKIA. J of IMAB. 2012; 18(4):240-242. doi: 10.5272/ jimab.2012184.240.

REFERENCES:
1. Lalabonova Hr, Firkova E. Lasers in Dentistry. Physical medicine, rehabilitation, health. 2006, 4, 4 – 9. [in Bulgarian]
2. Bánóczy J, Csiba A. Comparative study of the clinical picture and histopathologic structure of oral leucoplakia. Cancer. 1972 May;29(5):1230-1234. [PubMed]
3. Bokor-Bratic M. The prevalence of precancerous oral lesions. Oral leukoplakia. Archive of Oncology. 2000; 8(4):169-70.
4. Chiesa F, Tradati N, Grigolato R, Boracchi P, Biganzoli E, Crose N, et all. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results. Int J Cancer. 2005 Jul 1;115(4)625–629. [PubMed] [CrossRef]
5. Gillenwater A, Papadimitrakopoulou V, Richards-Kortum R. Oral Premalignancy: New Methods of Detection and Treatment. Curr Oncol Repor. 2006 Mar;8(2):146–154. [PubMed]
6. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol. 2003 Dec;39(8)759–769. [PubMed] [CrossRef]
7. Kademani D, Dierks E. Surgical Management of Oral and Mucosal Dysplasias: The Case for Surgical Excision. J Oral Maxillofac Surg.  2007 Feb;65(2):287-292. [PubMed] [CrossRef]
8. Novakovic D, Rickert S, Blitzer A. Office-based laser treatment of oral premalignant lesions. Operative Techniques in Otolaryngology. 2011,  22, 159-164.
9. Roed-Peterson B, Gupta PC, Pindborg JJ, Sing B. Association between oral leukoplakia and sex, age, and tobacco habits. Bull World Health Organ. 1972; 47(1):13-19. [PubMed]
10. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009 Apr-May;45(4-5):317–323. [PubMed] [CrossRef]
11. Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gupta AK. Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery. Lasers Med Sci. 2008 Oct;23(4):375-379. [PubMed] [CrossRef]
12. Warnakulasuriya S, Johnson N, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575–80. [PubMed] [CrossRef].

Accepted for publication: 07 May 2012
Issue published online: 28 August 2012

back to Online Journal